Chronic Kidney Disease-Mineral and Bone Disorder

Suetonia C. Palmer, Giovanni F.M. Strippoli, Jonathan C. Craig, Donald A. Molony

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Citation (Scopus)

Abstract

Chronic kidney disease-mineral and bone disorder (CKD-MBD) is commonly encountered in the later stages of chronic kidney failure (CKD). A range of treatments are used to correct the metabolic abnormalities observed with CKD-MBD. This chapter examines the evidence for management of CKD-MBD in adults, including transplant-related bone disease. The heterogeneity in clinical and biochemical abnormalities of CKD-MBD makes it difficult to determine its exact prevalence in patients with CKD. Diagnostic tests for renal osteodystrophy would ideally examine the essential properties of bone: strength for load bearing, flexibility to absorb energy, compression, and tension without fracture, and volume and weight to facilitate mobility. Phosphate binders reduce phosphorus absorption from dietary content through binding within the gut. Bisphosphonates are used widely for the treatment and prevention of osteoporosis and its complications in the general population.

Original languageEnglish
Title of host publicationEvidence-Based Nephrology, Second Edition
Subtitle of host publicationVolume 1
EditorsJonathan C. Craig, Donald A. Molony, Giovanni F.M. Strippoli
Place of PublicationHoboken, NJ
PublisherWiley
Chapter36
Pages589-616
Number of pages28
Volume1
ISBN (Electronic)9781119105954
ISBN (Print)9781119105923
DOIs
Publication statusPublished - 2023

Keywords

  • bisphosphonates
  • chronic kidney disease-mineral and bone disorder
  • chronic kidney failure
  • renal osteodystrophy
  • transplant-related bone disease

Fingerprint

Dive into the research topics of 'Chronic Kidney Disease-Mineral and Bone Disorder'. Together they form a unique fingerprint.

Cite this